Title:
COMBINATION OFTIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE
Document Type and Number:
WIPO Patent Application WO/2018/009507
Kind Code:
A8
Abstract:
Provided are methods and compositions for treating cancer using an effective amount of a PD-1 antagonist (e.g., an antibody) in combination with a TIM-4 antagonist (e.g., an antibody).
Inventors:
DOYLE SEAN (US)
SELBY MARK (US)
CHADWICK ERIC (US)
SELBY MARK (US)
CHADWICK ERIC (US)
Application Number:
PCT/US2017/040665
Publication Date:
February 07, 2019
Filing Date:
July 05, 2017
Export Citation:
Assignee:
BRISTOL MYERS SQUIBB CO (US)
International Classes:
C07K16/28; A61K39/00
Attorney, Agent or Firm:
REMILLARD, Jane, E. et al. (US)
Download PDF:
Previous Patent: ERYTHROID-SPECIFIC PROMOTER AND METHOD OF USE THEREOF
Next Patent: LASER MARKING SYSTEM WITH THROUGH-THE-LENS AUTOFOCUS
Next Patent: LASER MARKING SYSTEM WITH THROUGH-THE-LENS AUTOFOCUS